Stock listing

Otsuka Holdings Co., Ltd.

Selected listing: OS1 · MUN · EUR · DE

Otsuka Holdings Co., Ltd. (Munich:OS1), Health Technology. Latest release Oct 7, 2026: Otsuka Completes Rolling Submission of Supplemental Biologics License…

OS1:MUNEURDEUpdated September 26, 2026

Ticker: Munich:OS1
Asset type: Stock
Sector: Health Technology
Industry: Pharmaceuticals: Major
Exchange: Munich
Currency: EUR

Latest news from Otsuka Holdings Co., Ltd.

Otsuka Completes Rolling Submission of Supplemental Biologics License Application (sBLA) for Traditional Approval of VOYXACT in U.S.

October 7, 2026

NDA Submission Initiated for Zipalertinib Plus Chemotherapy in First-Line EGFR Exon 20 Insertion Mutation NSCLC for Review Under FDA RTOR Program

October 1, 2026

Notice regarding the status of share repurchases

October 1, 2026

Otsuka Presents New Phase 3b Results for SIMTRIYO® (centanafadine) Highlighting Consistent Improvements Across ADHD Symptoms, Anxiety, and Associated Features in Adults with ADHD and Comorbid Anxiety Disorders at Psych Congress 2026

September 18, 2026

Zipalertinib Plus Chemotherapy Demonstrates 6-Month Median PFS Benefit in Phase 3 Trial in First-Line EGFR Exon 20 Insertion Mutation NSCLC

September 13, 2026

All Otsuka Holdings Co., Ltd. news →

Research Otsuka Holdings Co., Ltd.

Otsuka Holdings Co., Ltd. company profile

View the public company page for Otsuka Holdings Co., Ltd. on 6ix.

Otsuka Holdings Co., Ltd. news

Read company news and market updates connected to Otsuka Holdings Co., Ltd..

Otsuka Holdings Co., Ltd. investor events

Find investor webinars, events, and replay context for Otsuka Holdings Co., Ltd..